Skip to content

Clinical trials

Recruiting Phase 1 Alzheimer Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Phase: Phase 1 Status: Recruiting Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20201
20213
20223
20232
20246
202512
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting38

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company4
Alnylam Pharmaceuticals2
Denali Therapeutics Inc.2
Xuanwu Hospital, Beijing2
AC Immune SA1
Academia Sinica, Taiwan1
Amyloid Solution Inc1
Anhui Provincial Hospital1
Augusta University1
BnH Research1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease38
Cognitive Dysfunction10
Dementia6
Neurodegenerative Diseases3
Frontotemporal Dementia2
Parkinson Disease2
Tauopathies2
Amyotrophic Lateral Sclerosis1
Aphasia1
Aphasia, Primary Progressive1

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.